- Punicalin
-
- $43.00 / 1mg
-
2025-06-30
- CAS:65995-64-4
- Min. Order:
- Purity: 99.95%
- Supply Ability: 10g
- Ellagic Acid
-
- $0.00 / 1kg
-
2023-04-04
- CAS:65995-64-4
- Min. Order: 1kg
- Purity: 40%-95%
- Supply Ability: 100kg
- Punicalin
-
- $0.00 / 5mg
-
2023-02-24
- CAS:65995-64-4
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
|
| | punicalin Basic information |
| Product Name: | punicalin | | Synonyms: | 4,6-Gallagylglucose;punicalin;4-O,6-O-[(aS)-[2,2'-[(5,10-Dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran)-1,6-diyl]bis[3,4,5-trihydroxyphenyl]]dicarbonyl]-β-D-glucopyranose;D-Glucose cyclic 4,6-[(2S,2'S)-2,2'-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]];Punicalin
D-Glucose cyclic 4,6-[(2S,2'S)-2,2'-(5,10-dihydro-2,3,7,8-tetrahydroxy-5,10-dioxo[1]benzopyrano[5,4,3-cde][1]benzopyran-1,6-diyl)bis[3,4,5-trihydroxybenzoate]];4,6-Gallagyl-D-glucose;Punicalin, mixture of anomers;PubChem ID: 5388496 | | CAS: | 65995-64-4 | | MF: | C34H22O22 | | MW: | 782.53 | | EINECS: | | | Product Categories: | chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract | | Mol File: | 65995-64-4.mol |  |
| | punicalin Chemical Properties |
| Boiling point | 1548.3±65.0 °C(Predicted) | | density | 2.036 | | storage temp. | -20°C | | solubility | DMSO: soluble | | form | Solid | | pka | 1.93±0.60(Predicted) | | color | Light yellow to green yellow |
| WGK Germany | 3 | | HS Code | 2938909090 |
| | punicalin Usage And Synthesis |
| Uses | Refer to the productμs Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support. | | Definition | ChEBI: Punicalin is a tannin. | | in vivo | Punicalin (5 mg/kg, subcutaneous injection) has an obvious anti-inflammatory effect on carrageenan (HY-125474)-induced metatarsal edema in rats[1].
Punicalin (10 mg/kg, intraperitoneal injection) alleviates LPS (HY-D1056)-induced acute lung injury in mice by inhibiting the production of inflammatory cytokines and MAPK/ NF-κB signaling[5].
| Animal Model: | Carrageenan (HY-125474)-induced Edema in rats[1] | | Dosage: | 5 mg/kg | | Administration: | s.c. | | Result: | Showed significant anti-inflammatory effect against carrageenan induced paw edema at all time intervals, but decreased the effects.with larger dose. |
| Animal Model: | LPS (HY-D1056)-induced acute lung injury mice[5] | | Dosage: | 10 mg/kg | | Administration: | i.p. | | Result: | Reduced the mortality and attenuated the severity of lung pathological injury.
Ameliorated LPS (HY-D1056)-induced lung edema and vascular leakage.
|
|
| | punicalin Preparation Products And Raw materials |
|